Agonistic/JJ
activity/NN
of/IN
a/DT
CD40-specific/JJ
single-chain/JJ
Fv/NN
constructed/VBN
from/IN
the/DT
variable/JJ
regions/NNS
of/IN
mAb/NN
G28-5/NN
./.

A/DT
single-chain/JJ
Fv/NN
(/(
sFv/NN
)/)
was/VBD
expressed/VBN
from/IN
the/DT
variable/JJ
regions/NNS
of/IN
the/DT
CD40-specific/JJ
mAb/NN
G28-5/NN
./.
=====
The/DT
molecule/NN
bound/VBD
CD40/NN
with/IN
a/DT
high/JJ
affinity/NN
(/(
2.2/CD
nM/NN
)/)
and/CC
was/VBD
a/DT
monomer/NN
in/IN
solution/NN
./.
=====
Surprisingly/RB
,/,
G28-5/NN
sFv/NN
was/VBD
a/DT
potent/JJ
CD40/NN
agonist/NN
that/WDT
rapidly/RB
crosslinked/VBD
CD40/NN
on/IN
the/DT
cell/NN
surface/NN
but/CC
did/VBD
not/RB
crosslink/VB
CD40-Ig/NN
in/IN
solution/NN
./.
=====
G28-5/NN
sFv/NN
was/VBD
a/DT
more/RBR
potent/JJ
agonist/NN
than/IN
G28-5/NN
IgG/NN
and/CC
was/VBD
able/JJ
to/TO
stimulate/VB
CD40/NN
responses/NNS
by/IN
B/NN
cells/NNS
and/CC
monocytes/NNS
./.
=====
G28-5/NN
IgG/NN
partially/RB
blocked/VBD
,/,
whereas/IN
G28-5/NN
sFv/NN
augmented/VBD
CD40/NN
responses/NNS
during/IN
stimulation/NN
with/IN
natural/JJ
ligand/NN
(/(
gp39-CD8/JJ
fusion/NN
protein/NN
)/)
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
the/DT
functional/JJ
activity/NN
of/IN
ligands/NNS
built/VBN
from/IN
the/DT
binding/VBG
site/NN
of/IN
G28-5/NN
is/VBZ
highly/RB
dependent/JJ
upon/IN
the/DT
size/NN
and/CC
physical/JJ
properties/NNS
of/IN
the/DT
molecule/NN
both/CC
in/IN
solution/NN
and/CC
on/IN
the/DT
cell/NN
surfaces/NNS
./.